Evidence map›Paper›PMID 29581224›Full record

ArticleJournal of the American Heart Association2018

Vascular Cognitive Impairment Linked to Brain Endothelium Inflammation in Early Stages of Heart Failure in Mice.

Mateusz G Adamski, Magdalena Sternak, Tasnim Mohaissen, Dawid Kaczor, Joanna M Wierońska, Monika Malinowska, Iwona Czaban, Katarzyna Byk, Kristina S Lyngsø, Kamil Przyborowski and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Intraperitoneal Injection of theInternational journal of molecular sciences · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. A functional cerebral endothelium is necessary to protect against cognitive decline.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Mateusz G AdamskiJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Kraków, Poland adamskimateusz@yahoo.com stefan.chlopicki@jcet.eu.
Magdalena SternakJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Kraków, Poland.
Tasnim MohaissenJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Kraków, Poland.
Dawid KaczorJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Kraków, Poland.
Joanna M WierońskaInstitute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.
Monika MalinowskaNencki Institute of Experimental Biology, Polish Academy of Science, Warsaw, Poland.
Iwona CzabanNencki Institute of Experimental Biology, Polish Academy of Science, Warsaw, Poland.
Katarzyna BykInstitute of Nuclear Physics, Polish Academy of Sciences, Warsaw, Poland.
Kristina S LyngsøUniversity of Southern Denmark, Odense, Denmark.
Kamil PrzyborowskiJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Kraków, Poland.
Pernille B L HansenUniversity of Southern Denmark, Odense, Denmark.
Grzegorz WilczyńskiNencki Institute of Experimental Biology, Polish Academy of Science, Warsaw, Poland.
Stefan ChlopickiJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Kraków, Poland adamskimateusz@yahoo.com stefan.chlopicki@jcet.eu.
Jagiellonian University · PLInstytut Biologii Doświadczalnej im. Marcelego Nenckiego · PLUniversity of Southern Denmark · DKInstitute of Nuclear Physics, Polish Academy of Sciences · PLMaj Institute of Pharmacology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough advanced heart failure (HF) is a clinically documented risk factor for vascular cognitive impairment, the occurrence and pathomechanisms of vascular cognitive impairment in early stages of HF are equivocal. Here, we characterize vascular cognitive impairment in the early stages of HF development and assess whether cerebral hypoperfusion or prothrombotic conditions are involved. METHODS AND

resultsTgαq*44 mice with slowly developing isolated HF triggered by cardiomyocyte-specific overexpression of G-αq*44 protein were studied before the end-stage HF, at the ages of 3, 6, and 10 months: before left ventricle dysfunction; at the stage of early left ventricle diastolic dysfunction (with preserved ejection fraction); and left ventricle diastolic/systolic dysfunction, respectively. In 6- to 10-month-old but not in 3-month-old Tgαq*44 mice, behavioral and cognitive impairment was identified with compromised blood-brain barrier permeability, most significantly in brain cortex, that was associated with myelin sheet loss and changes in astrocytes and microglia. Brain endothelial cells displayed increased E-selectin immunoreactivity, which was accompanied by increased amyloid-β

conclusionsWe report for the first time that vascular cognitive impairment is already present in the early stage of HF development, even before left ventricle systolic dysfunction. The underlying pathomechanism, independent of brain hypoperfusion, involves preceding platelet hyperreactivity and brain endothelium inflammatory activation.

Indexed as

Behavior, AnimalAmyloid beta-PeptidesAnimalsBlood-Brain BarrierBlood PlateletsBrainCapillary PermeabilityCerebral ArteriesCerebrovascular CirculationCognitionCognition DisordersDementia, VascularDisease Models, AnimalDisease ProgressionEncephalitisEndothelium, VascularAmyloid beta-Peptidesamyloid beta-protein (1-42)GTP-Binding Protein alpha Subunits, Gq-G11Peptide Fragmentsblood‐brain barriercognitive impairmentendotheliumheart failureplatelet

Identifiers

PMID29581224
PMCPMC5907583
OpenAlexW2793506158

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.